Wczytywanie spółki
Keep exploring
The themes Johnson & Johnson is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The themes it is part of
- Wyselekcjonowana
Medical devices
Od InspectStocks · 20 companies
Surgical robots, implants, heart devices, glucose monitors and other medical equipment.
- Kurs, 1 rok
- +6,2%
- Przychody, 1 rok
- +7,2%
+14A 8B 7C 3D 2
- Wyselekcjonowana
Big pharma
Od InspectStocks · 13 companies
The largest drugmakers, selling prescription medicines worldwide.
- Kurs, 1 rok
- +41,6%
- Przychody, 1 rok
- +10,8%
+7A 7B 3C 3
Highest-graded in Drug Manufacturers General
Graded A or B and worth $2B or more: A first, then the largest.
- LLYELI Lilly And Company1,36T USDA+
- MRKMerck & Co., Inc.364,3B USDA
- NVSNovartis AG306,3B USDA
AMGNAmgen Inc.251,9B USDA+
GILDGilead Sciences, Inc.208,4B USDA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 paź 2026CBGraded C, now B
MCKMckesson Corporation4 lis 2026BAGraded B, now A
CVSCVS Health Corp4 lis 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 lis 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 paź 2026CAGraded C, now A
Jak zarabia
- Innovative Medicine64%
- MedTech36%
Udziały w przychodach to szacunki za six months ended June 28, 2026, high confidence, a nie dane z raportu złożonego do regulatora.
Konkuruje z
Co sprzedaje6
DARZALEX
A medicine used to treat multiple myeloma, a cancer of plasma cells.
TREMFYA
A medicine for conditions including plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
CARVYKTI
A treatment made from a patient’s modified immune cells for multiple myeloma that has returned or has not responded to earlier treatment.
Pokaż 3 więcej
VARIPULSE
A system that uses pulsed electrical energy to treat atrial fibrillation, a disorder that causes an irregular heartbeat.
Impella
A heart pump used to support blood circulation in certain patients with heart failure or during high-risk heart procedures.
ACUVUE
A brand of contact lenses sold for vision correction.
Kto to kupuje4
- Wholesalers, distributors and retailers that buy medicines and medical products for resale.
- Hospitals and clinics that buy medicines and devices for patient care and procedures.
- Physicians and other healthcare professionals who prescribe medicines or use medical devices in treatment.
- Eye-care professionals and retailers that supply contact lenses and other vision products.
Na czym się opiera i co może to zburzyć
Od czego zależy ta działalność
- 1Some medicines rely on licenses or partnerships with other companies. For example, a subsidiary licenses patent families related to DARZALEX from Genmab, and IMBRUVICA is co-commercialized in the United States with Pharmacyclics, an AbbVie company.
- 2The company depends on government approvals and ongoing oversight for its medicines and medical devices, including rules on safety, manufacturing, labeling and sales.
- 3Sales depend partly on health insurers and government programs deciding whether to cover products and how much they will reimburse; U.S. and other governments can also change medicine-pricing rules.
- 4The company uses third parties to make or supply some products and relies on complex international manufacturing and distribution chains.
Co może pójść nie tak
- 1Generic and biosimilar competition can reduce sales of medicines when alternatives enter the market. The latest quarterly report describes continuing sales declines for STELARA and says biosimilar competition is also affecting other medicines.
- 2Government pricing rules, coverage decisions and reimbursement changes can affect what the company receives for medicines and medical devices. The company identifies U.S. drug-pricing measures and tighter regulation across markets as concerns.
- 3Lawsuits and product-safety claims can lead to substantial costs and affect sales or reputation. The latest quarterly report recorded charges related to talc litigation.
Pełne sprawozdania finansowe →
O spółce Johnson & Johnson
Johnson & Johnson develops, makes and sells prescription medicines and medical devices around the world. Its two businesses are Innovative Medicine, which sells medicines for conditions including cancer and immune disorders, and MedTech, which sells products used in heart procedures, surgery, orthopaedics and vision care.
- Siedziba
- New Brunswick, New Jersey
- Rok założenia
- 1887 (founding year, high confidence)
- Zatrudnienie
- 140,800 (December 28, 2025, high confidence)
- Notowana na
- New York Stock Exchange
- Koniec roku obrotowego
- Last Sunday in December
Zbudowane z własnych raportów spółki Johnson & Johnson składanych do amerykańskiej Komisji Papierów Wartościowych i Giełd (SEC). Liczby są takie, jak zaraportowano, a historia na akcję przeliczona na dzisiejszą bazę akcji. To opisuje firmę — nie jest poradą inwestycyjną ani rekomendacją kupna lub sprzedaży.